Biotx.ai delivers predictive biomarkers as a basis for decision support in precision medicine. They use novel, state of the art, machine learning approaches specifically designed to find complex patterns in biomedical data.
Focus: Genomics-focused drug discovery platform
Team: Joern Klinger (CEO) and Marco Schmidt (CSO)
Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.Contact Marco
Copyright © 2023 Stevenage Bioscience Catalyst